Jaishil Shah

Jaishil leads Deloitte India’s LSHC practice for Risk Advisory and is responsible for the overall strategic direction of the life sciences and health care practice. Jaishil has over 20+ years of post-qualification experience as a professional consultant across India and International markets.

He is a leader who has developed innovative market solutions that leverage exponential technologies, data, and analytics to transform Life science & healthcare. In that capacity, Jaishil is responsible for the overall sector which includes providing advisory services to clients in the pharmaceutical, medical device, and consumer healthcare segments.

His knowledge and expertise are in Data Analytics, Third Party Risk Management, Process Transformation, Enterprise risk management, Internal Audit, and preparation & implementation of the model business process.

Jaishil has led various projects across various Indian and International markets (Regulated & Semi-regulated markets) with the objective of enhancing and protecting Corporate Governance by providing risk-based consulting, business transformation, and analytical insights. Jaishil has helped organizations perform optimally in a constantly evolving environment through Supply chain operations transformation, cost reduction on indirect spending, enhancement of special rate process, pharma & healthcare-related data analytics, rationalization of marketing spends, process & policy enhancement of institutional/special rate business, identification of key risks, and risk management at an enterprise-wide level.

Some of the major life science & Healthcare clients served by Jaishil during his experience in Deloitte include Cipla Limited, Novartis, DRL, Teva Pharmaceuticals, Indira IVF Hospitals, and Apollo Hospitals (Third Party Risk Management), MSD & Meril Life science, Nutricia.